Literature DB >> 34705561

Characterization of M116.1p, a Murine Cytomegalovirus Protein Required for Efficient Infection of Mononuclear Phagocytes.

Tina Ružić1, Vanda Juranić Lisnić1,2, Hana Mahmutefendić Lučin3, Tihana Lenac Roviš1, Jelena Železnjak1,2, Maja Cokarić Brdovčak1,2, Ana Vrbanović1,2, Deni Oreb1, Daria Kveštak1,2, Kristina Gotovac Jerčić4,5, Fran Borovečki4,5, Pero Lučin3, Barbara Adler6, Stipan Jonjić1,2, Berislav Lisnić1,2.   

Abstract

Broad tissue tropism of cytomegaloviruses (CMVs) is facilitated by different glycoprotein entry complexes, which are conserved between human CMV (HCMV) and murine CMV (MCMV). Among the wide array of cell types susceptible to the infection, mononuclear phagocytes (MNPs) play a unique role in the pathogenesis of the infection as they contribute both to the virus spread and immune control. CMVs have dedicated numerous genes for the efficient infection and evasion of macrophages and dendritic cells. In this study, we have characterized the properties and function of M116, a previously poorly described but highly transcribed MCMV gene region that encodes M116.1p, a novel protein necessary for the efficient infection of MNPs and viral spread in vivo. Our study further revealed that M116.1p shares similarities with its positional homologs in HCMV and RCMV, UL116 and R116, respectively, such as late kinetics of expression, N-glycosylation, localization to the virion assembly compartment, and interaction with gH-a member of the CMVs fusion complex. This study, therefore, expands our knowledge about virally encoded glycoproteins that play important roles in viral infectivity and tropism. IMPORTANCE Human cytomegalovirus (HCMV) is a species-specific herpesvirus that causes severe disease in immunocompromised individuals and immunologically immature neonates. Murine cytomegalovirus (MCMV) is biologically similar to HCMV, and it serves as a widely used model for studying the infection, pathogenesis, and immune responses to HCMV. In our previous work, we have identified the M116 ORF as one of the most extensively transcribed regions of the MCMV genome without an assigned function. This study shows that the M116 locus codes for a novel protein, M116.1p, which shares similarities with UL116 and R116 in HCMV and RCMV, respectively, and is required for the efficient infection of mononuclear phagocytes and virus spread in vivo. Furthermore, this study establishes the α-M116 monoclonal antibody and MCMV mutants lacking M116, generated in this work, as valuable tools for studying the role of macrophages and dendritic cells in limiting CMV infection following different MCMV administration routes.

Entities:  

Keywords:  cytomegalovirus; intranasal infection; macrophages; mononuclear phagocyte; mouse cytomegalovirus; viral assembly compartment; viral pathogenesis; virus entry

Mesh:

Substances:

Year:  2021        PMID: 34705561      PMCID: PMC8791281          DOI: 10.1128/JVI.00876-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  114 in total

1.  Identification and characterization of a novel serine-arginine-rich splicing regulatory protein.

Authors:  D C Barnard; J G Patton
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Genes of murine cytomegalovirus exist as a number of distinct genotypes.

Authors:  Lee M Smith; Geoffrey R Shellam; Alec J Redwood
Journal:  Virology       Date:  2006-06-16       Impact factor: 3.616

3.  Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control.

Authors:  I Crnković-Mertens; M Messerle; I Milotić; U Szepan; N Kucić; A Krmpotić; S Jonjić; U H Koszinowski
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells.

Authors:  Julie Helft; Jan Böttcher; Probir Chakravarty; Santiago Zelenay; Jatta Huotari; Barbara U Schraml; Delphine Goubau; Caetano Reis e Sousa
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

5.  Understanding anomalous mobility of proteins on SDS-PAGE with special reference to the highly acidic extracellular domains of human E- and N-cadherins.

Authors:  Prince Tiwari; Pallavi Kaila; Purnananda Guptasarma
Journal:  Electrophoresis       Date:  2019-02-12       Impact factor: 3.535

6.  Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice.

Authors:  T W Booth; A A Scalzo; C Carrello; P A Lyons; H E Farrell; G R Singleton; G R Shellam
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice.

Authors:  T M Collins; M R Quirk; M C Jordan
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Host subspecific viral strains in European house mice: Murine cytomegalovirus in the Eastern (Mus musculus musculus) and Western house mouse (Mus musculus domesticus).

Authors:  Dagmar Čížková; Stuart J E Baird; Jana Těšíková; Sebastian Voigt; Ďureje Ľudovít; Jaroslav Piálek; Joëlle Goüy de Bellocq
Journal:  Virology       Date:  2018-06-09       Impact factor: 3.616

Review 9.  Development of novel vaccines against human cytomegalovirus.

Authors:  Xinle Cui; Clifford M Snapper
Journal:  Hum Vaccin Immunother       Date:  2019-04-24       Impact factor: 3.452

10.  BLAST: a more efficient report with usability improvements.

Authors:  Grzegorz M Boratyn; Christiam Camacho; Peter S Cooper; George Coulouris; Amelia Fong; Ning Ma; Thomas L Madden; Wayne T Matten; Scott D McGinnis; Yuri Merezhuk; Yan Raytselis; Eric W Sayers; Tao Tao; Jian Ye; Irena Zaretskaya
Journal:  Nucleic Acids Res       Date:  2013-04-22       Impact factor: 16.971

View more
  1 in total

1.  ChAdOx1-S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination.

Authors:  Maja Cokarić Brdovčak; Jelena Materljan; Marko Šustić; Sanda Ravlić; Tina Ružić; Berislav Lisnić; Karmela Miklić; Ilija Brizić; Marina Pribanić Matešić; Vanda Juranić Lisnić; Beata Halassy; Dobrica Rončević; Zdravka Knežević; Leo Štefan; Federico Bertoglio; Maren Schubert; Luka Čičin-Šain; Alemka Markotić; Stipan Jonjić; Astrid Krmpotić
Journal:  Eur J Immunol       Date:  2022-03-31       Impact factor: 6.688

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.